Softwr

Healthcare · head to head

NextGen Healthcare vs PathAI

NextGen Healthcare logo

NextGen Healthcare

Healthcare

Integrated EHR and practice management solutions

From
$150/month
Rated
-
Full reviewWebsite
PathAI logo

PathAI

Healthcare

Digital pathology image management with an FDA cleared platform for primary diagnosis

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: NextGen Healthcare no pricing published on website; PathAI aISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • They diverge on capability: NextGen Healthcare covers Electronic Health Records, PathAI covers AISight image management.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which NextGen Healthcare and PathAI actually diverge.

Attributes where NextGen Healthcare and PathAI differ
AttributeNextGen HealthcarePathAI
Starting price$150/monthOn request
Pricing modelsubscriptionquote
PlatformsWeb, iOS, AndroidWeb
Founded1997Unknown

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in NextGen Healthcare

  • Electronic Health Records
  • Practice Management
  • Revenue Cycle Management
  • Telehealth
  • Analytics
  • Labs
  • Pharmacies
  • Clearinghouses

Only in PathAI

  • AISight image management
  • AISight Dx
  • Scanner interoperability
  • Case and worklist management
  • AI algorithm deployment
  • Biopharmaceutical research tooling
  • LIS integration

What people use each for

The jobs each tool is most often brought in to do.

NextGen Healthcare

  • Cloud-based EHR and practice management for ambulatory and specialty practicesnot PathAI
  • AI-assisted clinical documentation to reduce after-hours charting timenot PathAI

PathAI

  • An academic medical centre going digital for primary diagnosis that needs the FDA cleared AISight Dx configuration rather than the research labelled versionnot NextGen Healthcare
  • A reference laboratory consolidating subspecialty sign out across sites so a specialist pathologist can read cases from any locationnot NextGen Healthcare
  • A pharmaceutical company needing consistent quantitative scoring of trial biopsies across many sites and readersnot NextGen Healthcare
  • A laboratory with a mixed scanner estate that needs one image management layer rather than each scanner vendor viewernot NextGen Healthcare

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

NextGen Healthcare

  • No pricing published on website

PathAI

  • AISight is labelled research use only and cannot be used for primary diagnosis; only AISight Dx carries the FDA clearance and CE-IVD mark, and laboratories regularly buy the wrong configuration and discover they cannot sign out on it.
  • The software licence is usually the smallest line in a digital pathology project, behind scanners, storage and network capacity, so a business case built around the software cost understates the real investment by a wide margin.
  • Whole slide images are very large, so a laboratory that does not model storage growth and retention policy from the start faces storage costs that grow faster than case volume and dominate the renewal.
  • Clinical validation is required per subspecialty rather than once for the platform, which means dermatopathology, gastrointestinal and breast each need their own concordance study and pathologist time before go live.
  • PathAI competes against pathology incumbents that also sell the scanners, and a laboratory buying an independent image management layer takes on the integration risk between scanner vendor and software vendor itself.

Pricing, plan by plan

NextGen Healthcare

$150/month

No published plan breakdown. See the NextGen Healthcare review.

PathAI

On request
  • AISight$undefined/year
    • Priced by annual slide or case volume and by pathologist seats
    • AISight Dx, the clinically cleared configuration, quoted separately from research use AISight
    • Image storage priced by capacity and retention policy

Which should you pick?

Choose NextGen Healthcare if

  • You need electronic health records.
  • You work on Web, iOS, Android.
  • You also want practice management.
NextGen Healthcare review

Choose PathAI if

  • You need aisight image management.
  • You also want aisight dx.
PathAI review

Questions people ask

Is NextGen Healthcare or PathAI better?
Neither clearly leads. NextGen Healthcare starts at $150/month and PathAI at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, NextGen Healthcare or PathAI?
NextGen Healthcare starts at $150/month and PathAI at On request.
Does NextGen Healthcare or PathAI run on more platforms?
NextGen Healthcare runs on Web, iOS, Android. PathAI runs on Web.
What is NextGen Healthcare best used for?
NextGen Healthcare is most often used for cloud-based ehr and practice management for ambulatory and specialty practices, ai-assisted clinical documentation to reduce after-hours charting time. Of those, cloud-based ehr and practice management for ambulatory and specialty practices and ai-assisted clinical documentation to reduce after-hours charting time are not what PathAI is typically brought in for.
What can NextGen Healthcare do that PathAI cannot?
NextGen Healthcare covers Electronic Health Records, Practice Management, Revenue Cycle Management, Telehealth. PathAI covers AISight image management, AISight Dx, Scanner interoperability, Case and worklist management.

Answered from the vendors’ own pages

NextGen Healthcare: How much does NextGen Healthcare cost?

NextGen Healthcare does not publish pricing on its website. The company directs customers to schedule a meeting, request a demo, or chat with sales to receive custom pricing.

Source
PathAI: What is the difference between AISight and AISight Dx?

AISight is for research use only and not for clinical diagnostic use. AISight Dx received FDA 510(k) clearance in June 2025 for primary diagnosis and is CE-IVD marked in the EEA, UK and Switzerland. Only the Dx configuration can be used to sign out cases.

PathAI: Can we use our existing scanners?

Yes. AISight is designed to ingest images from multiple whole slide scanner vendors, which is one of the main reasons laboratories choose an independent image management layer.

PathAI: Do the AI algorithms carry the same clearance as the platform?

No. The platform clearance covers image management for primary diagnosis. Individual algorithms have their own labelling, and many are research use only. Check each one separately.

PathAI: Is pricing published?

No. It is quoted by slide or case volume, pathologist seats and storage, with the clinically cleared configuration priced separately.

Share

Related pages

More on NextGen Healthcare

More on PathAI

Keep looking

Other head to heads